Heartbeam Inc. Warrant
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.32
- Today's High:
- $0.32
- Open Price:
- $0.32
- 52W Low:
- $0.2001
- 52W High:
- $1.5
- Prev. Close:
- $0.3998
- Volume:
- 16
Company Statistics
- Market Cap.:
- $0
- Book Value:
- 0.296
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -90.31%
- Return on Equity TTM:
- -164.24%
Company Profile
Heartbeam Inc. Warrant had its IPO on 2021-11-11 under the ticker symbol BEATW.
The company operates in the Healthcare sector and Health Information Services industry. Heartbeam Inc. Warrant has a staff strength of 15 employees.
Stock update
Shares of Heartbeam Inc. Warrant opened at $0.32 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.32 - $0.32, and closed at $0.32.
This is a -19.96% slip from the previous day's closing price.
A total volume of 16 shares were traded at the close of the day’s session.
In the last one week, shares of Heartbeam Inc. Warrant have slipped by -34.69%.
Heartbeam Inc. Warrant's Key Ratios
Heartbeam Inc. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Heartbeam Inc. Warrant’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Heartbeam Inc. Warrant's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Heartbeam Inc. Warrant’s operating margin was 0% while its return on assets stood at -90.31% with a return of equity of -164.24%.
In Q1, Heartbeam Inc. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Heartbeam Inc. Warrant’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.495 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Heartbeam Inc. Warrant’s profitability.
Heartbeam Inc. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Heartbeam Inc. Warrant stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.46 million
- Total Liabilities
- $2.32 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Heartbeam Inc. Warrant ended 2024 with $1.46 million in total assets and $0 in total liabilities. Its intangible assets were valued at $1.46 million while shareholder equity stood at $-859000.00.
Heartbeam Inc. Warrant ended 2024 with $0 in deferred long-term liabilities, $2.32 million in other current liabilities, 1000.00 in common stock, $-26322000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $990000.00 and cash and short-term investments were $990000.00. The company’s total short-term debt was $0 while long-term debt stood at $0.
Heartbeam Inc. Warrant’s total current assets stands at $1.46 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.
In 2024, Heartbeam Inc. Warrant's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Heartbeam Inc. Warrant paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.32
- 52-Week High
- $1.5
- 52-Week Low
- $0.2001
- Analyst Target Price
- $
Heartbeam Inc. Warrant stock is currently trading at $0.32 per share. It touched a 52-week high of $1.5 and a 52-week low of $1.5. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.44 and 200-day moving average was $0.65 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Heartbeam Inc. Warrant
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.